Vérane Achard: Our editorial on the long-term results of the RTOG 0712
Vérane Achard, Radiation Oncologist and Chief Clinical Director at Fribourg Cantonal Hospital, shared a post on X about her recent paper published in the International Journal of Radiation Oncology Biology Physics:
“Honored to share this editorial with Robert Huddart, covering the long-term results of the RTOG 0712. While we wait for a miracle molecule that could eliminate the need for any local ttt, CRT therapy remains the only bladder preservation treatment for MIBC.”
Authors: Vérane Achard and Robert Huddart.
Vérane Achard is a Radiation Oncologist and Chief Clinical Director at Fribourg Cantonal Hospital. She holds a PhD in Physics, an MSc in Engineering and is a Private Lecturer at the University of Geneva. Dr. Achard also serves as the representative of GU Young and Early Career Investigators at the European Organisation for Research and Treatment of Cancer (EORTC).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023